Inspire Medical Systems, Inc.
INSP
$81.79
-$2.02-2.41%
NYSE
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 10.49% | 10.82% | 22.75% | 24.52% | 32.54% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 10.49% | 10.82% | 22.75% | 24.52% | 32.54% |
| Cost of Revenue | -1.93% | 16.18% | 24.04% | 28.28% | 32.88% |
| Gross Profit | 12.84% | 9.86% | 22.52% | 23.88% | 32.48% |
| SG&A Expenses | 21.84% | 20.77% | 14.86% | 14.02% | 15.14% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 13.76% | 15.52% | 13.15% | 13.44% | 13.25% |
| Operating Income | -32.64% | -165.03% | 90.24% | 242.95% | 206.29% |
| Income Before Tax | -33.33% | -121.50% | 144.46% | 140.39% | 347.88% |
| Income Tax Expenses | 97.87% | 19.66% | 79.54% | 196.02% | 437.94% |
| Earnings from Continuing Operations | -46.30% | -136.68% | 129.91% | 138.60% | 316.59% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -46.30% | -136.68% | 129.91% | 138.60% | 316.59% |
| EBIT | -32.64% | -165.03% | 90.24% | 242.95% | 206.29% |
| EBITDA | -17.61% | -98.49% | 110.84% | 239.75% | 227.37% |
| EPS Basic | -45.31% | -136.95% | 129.81% | 136.13% | 312.90% |
| Normalized Basic EPS | -11.83% | -84.08% | 144.33% | 137.90% | 343.67% |
| EPS Diluted | -43.57% | -138.03% | 129.41% | 132.40% | 306.33% |
| Normalized Diluted EPS | -10.39% | -83.71% | 143.47% | 136.38% | 337.65% |
| Average Basic Shares Outstanding | -1.83% | -0.75% | 0.29% | 1.05% | 1.75% |
| Average Diluted Shares Outstanding | -3.37% | -2.96% | 2.35% | 1.70% | 4.32% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |